On these bases and considering that CTGF is involved in the stimulation of the tumor microenvironment, including CAFs activation [46], we verified whether the GPER-mediated release of CTGF from MDA-MB-231 cells can trigger motile responses in BC-derived CAFs. The gene discussed is CCN2; the disease is breast cancer.